Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
30.10.25
/
50%
€3.82
Target price
30.10.26
€9.47
Performance (%)
84.56%
Price
02.01.26
€7.05
Summary
This prediction is currently active. With a performance of 84.56% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 30.10.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | 21.552% | 21.552% |
| iShares Core DAX® | 0.869% | 2.751% |
| iShares Nasdaq 100 | -0.852% | -2.079% |
| iShares Nikkei 225® | 0.436% | -1.741% |
| iShares S&P 500 | -0.122% | -0.584% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (NASDAQ:VNDA) had its price target lowered by analysts at Cantor Fitzgerald from $13.00 to $11.00. They now have an "overweight" rating on the stock.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
98.03%
02.01.26
02.01.26
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25